Back
Flotek Industries 10K Form
Sell
47
FTK
Flotek Industries
Last Price:
6.06
Seasonality Move:
13.32%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | FTK/Flotek Industries Quarterly |
2023-11-08 | 10Q | FTK/Flotek Industries Quarterly |
2023-08-09 | 10Q | FTK/Flotek Industries Quarterly |
2023-05-11 | 10Q | FTK/Flotek Industries Quarterly |
2022-11-10 | 10Q | FTK/Flotek Industries Quarterly |
2022-08-11 | 10Q | FTK/Flotek Industries Quarterly |
Receive FTK News And Ratings
See the #1 stock for the next 7 days that we like better than FTK
FTK Financial Statistics
Sales & Book Value
Annual Sales: | $188.06M |
---|---|
Cash Flow: | $-3.14M |
Price / Cash Flow: | 0 |
Annual Sales: | $3.57 |
Price / Book: | 1.4 |
Profitability
EPS (TTM): | 0.22000 |
---|---|
Net Income (TTM): | $6.93M |
Gross Margin: | $24.26M |
Return on Equity: | 6.8% |
Return on Assets: | 4.44% |
Flotek Industries Earnings Forecast
Key Flotek Industries Financial Ratios
- The Gross Profit Margin over the past 26 years for FTK is 12.90%.
- The Selling, General & Administrative Expenses for FTK have been equal to 14.82% of Gross Profit Margin.
- The Research & Development expenses have been 1.32% of Revenue.
- The Interest Expense is 11.56% of Operating Income.
- The Net Earning history of FTK is 13.14% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 14 years.
Flotek Industries Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Chemicals |
Sector: | Materials |
Current Symbol: | FTK |
CUSIP: | 343389 |
Website: | flotekind.com |
Debt
Debt-to-Equity Ratio: | 0.06 |
---|---|
Current Ratio: | 1.85 |
Quick Ratio: | 1.5 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 12.2 |
FTK Technical Analysis vs Fundamental Analysis
Sell
47
Flotek Industries (FTK)
is a Sell
Is Flotek Industries a Buy or a Sell?
-
Flotek Industries stock is rated a Sell
The current Flotek Industries [FTK] share price is $5.00. The Score for FTK is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.